相关实验视频
Updated: Jul 24, 2025
05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
4.6K
扭曲和应变功能障碍在扩张性心肌病发病的小鼠模型中的明显心力衰竭之前
Joshua B Holmes1, Madeleine E Lemieux2, Julian E Stelzer1
1Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio, United States.
概括
先进的心声回声检测到在明显心力衰竭 (HF) 之前扩张性心肌病 (DCM) 的小鼠模型中微妙的心脏机制缺陷. 这些早期的机械变化,没有通过标准措施,突出显示DCM潜在的致病触发因素.
科学领域:
- 心血管生理学心血管生理学
- 分子心脏病学分子心脏病学
- 生物医学成像技术 生物医学成像技术
背景情况:
- 对整个心脏机制的详细评估对于理解心肌病病变的发病过程至关重要.
- 传统的心声回声学可能会忽略微妙的心脏机械缺陷.
- 肌肉LIM蛋白 (MLP) 缺乏在小鼠模型中的扩张性心肌病 (DCM) 相关心力衰竭 (HF).
研究的目的:
- 采用先进的心声回声学和分析,以检测DCM的MLP缺陷小鼠模型中的临床前机械缺陷.
- 为了识别明显的缩性心力衰竭之前的心脏功能障碍的早期指标.
主要方法:
- 使用常规和四维 (4D) 心声学与斑点跟踪分析在MLP缺乏和野生类型的小鼠.
- 在多个年龄段 (3,6,10周) 评估左心室 (LV) 扭曲和应变力学.
- 与转录组分析 (RNA-seq) 和β-上腺素储备相关的机械发现.
主要成果:
- 缺乏MLP的小鼠在3周后表现出异常的LV扭力和应变力学以及降低的β-上腺素储备,尽管LVEF正常.
- 转录组分析显示,这些机械缺陷在大多数HF分子标志物之前发生.
- 由于MLP缺乏的小鼠老化并发展出缩功能障碍,HF的分子标志物变得上调.
结论:
- 微妙的LV机械缺陷,无法被LVEF和标准分子标记器检测,可以作为DCM相关的HF的病原性刺激.
- 先进的心声回声技术揭示了亚临床机械缺陷,为早期心肌病进展提供了洞察力.
- 这些方法在疾病模型中弥合了体外肉瘤功能和整个心脏机制之间的差距.
相关概念视频
01:30Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
01:29Heart Failure II: Pathophysiology
16
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
01:27Heart Failure I: Introduction
20
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
20